Introduction
Hyperglycemia and insulin resistance are common in critically ill patients, even if they have not previously had diabetes. The normalization of blood glwose levels with insulin therapy to far tighter levels than normally employed has recently been seen to improve the mo-lity of ICU patients by as much as 45% [I] .
Specifiially, the use of a Cham bandwidth blood gluwse monitoring and insulin therapy r e a e has been found to reduce mortality in critical care patients. The methodology restricted blood gluwse levels to approximately 5.8 mmoyL, the maximum level typically desired by diabetes clinicians. Normal critical care blood glucose h g e m e n t will often nllow for levels two times this value, with potentially increased patient risk.
Ambulatory diabetic individuals monitor food intake and daily activity to maintain blood sugar levels at an adequate level, In the ICU case patients are often hyperglycemic with no previous history, due to the stress the entire bodily system is undergoing. As a result, this condition can he far different from an ambulatory diabetic individual as ICU feeding. while variable in some cases, provides a known glucose input profile to a patient with a measurable insulin resistance. However, in each case high blood glucose levels must be tightly regulated using insulin therapy.
Though devices that can measure glucose Ievel and administer insulin exist, they do just that -measure and inject -with no automated interface between the two.
ICU patients typically have their blood glucose
Most commonly available glucose sensing devices operate by measuring the blood glucose content of a small finger-prick blood sample, an irritating method upon frequent use. However, recent advances in tec+ology suitable for ICU putients has been developed that enable blood glucose measurement at rates from every 0.6-7.0 minutes c2-41. With time constants on the order of minutes the faster of these rates are essentially continuous measurement. This rapid measurement enables feedback control, with knowledge of the glucose input, to be applied to minimize blood glucose levels toward the basal rate of 4.5-5.0 mmoVL, eliminating the exposure to elevated blood gluwse levels and the damage that can result.
TypiwUy, relaxed higher blood glucose levels are considered acceptable, as blood glucose management without automation does not typically deliver the data, or the ability to constantly modify insulin infusion rates to achieve tighter control. However, regular, automated blood glucose measurement provides the consistent volume of data necessary for such tight control, in conhast to the somelimes infrequent and inconsistent efforts available in busy critical care units. The ideal respmse would be a ilat line at the basal level [SI.
Whether it is in the area of understanding, modeling or managing diabetes 1 6 . 
Dynamic System Model
Comprehensive models, though they are very accurate in regimen evaluation, are generally unsuited for realtime control, requiring several time points of input to gmerate the insulin infusion profile. Additionally, they are not generic requiring patient-specific data and known glucose inputs. The aim of this research is to develop control schemes based on models that capture tho essential system dynamics, do not require unavailable data, and arc applicable to a wider variety of subjects. Simple models capture these essential dynamic behaviours, providing a more suitable foundation for real-time control design and analysis hat can be applied to a broad range of patients. 
Where G is the plasma glucose concentration over 
Most repotted controllers use a simple feedback loop that employs the blood glucose level above basal, G, and more rarely its' derivative, C, as sensor inputs, and the exogenous insulin infusion rate, u(t), as the control output. These controllers measure the output from Equation (I) while directly influencing Equation (3) via the control action. In between these two equations is the lime delay and dynamics of the remote compartment defied in Equation (2).
Derivation of Optimal Control
There are many complex influences between glucose and insdm concenhation for any person, normal or diabetic. However, L e steady state glucose concentration in the body is finally a function of how much insulin is present. The goal is to miniise excess glucose, G, and its rate of change, G , and ensure that excursions from the basal value, G , , , are minimised in magnitude. and duration with no hypoglycemic overshoot below the basal level. Ideally, blood sugar levels should be maintained in a tight range around the basal level, varying with glucose input, or feeding, level. This approach trends toward the concept that the ideal blood glucose curve should be relatively, if not completely, flat at G@)=O.
The optimal solution for U@ can he obtained analytically for the steady-state case where C=O is the desired condition that allows the optimal U@) that results in G=O to be determined.
First, Equation (3) is solved and the exact solution for Io) determined in terms of the exogenous insulin infusion U@.
Similarly, using Equation (Z), the solution for X@) is obtained in terms of I@) and, using Equation (4), directly expressed in terms of u(t)
Since the goal is to minimize G to approach or equal zero, the assumption of G = b = 0 at steady state is applied to Equation (I) to obtain a steady state optimal solution, from the remaining terms:
More specifically, setting &O is a means of obtaining the optimal solution for U@) to obtain any desired function or value of G. Since we desire, in the steady state that G O , the resulting exogenous insulin input,
U(), can be determined from Equation (6), using the expression forX(t) in terms of u(t) from Equation (S).
Note that if the patient is a diabetic andp,=O, the same result is obtained.
Substituting Equation (5) into Equation (6) and using the Laplace transform and its inverse, to simplify the convolution integrals and algebra, the optimal steady state exogenous insulin infusion function solution for U ( ) is obded:
to the result obtained from Equation (7) if P@) = 0. Since U" is the basal infusion rate of insulin in the absence of glucose input this result serves as a basic, but essential, check on the optimal control law derived. More specifically, it implies that the optimal control law revem to the basal infusion when there is no exogenous glucose input, as should be expected.
This optimal solution will provide an optimal insulin infusion profile for any case where the initial conditions match the steady state assumptions. It also does not employ blood sugar fecdback, being a closed form solution with knowledge of the glucose input, as most previously reprled literature. However, knowledge of the input limits the solution to specialized cases, such as the ICU.
Numerical Tests and Verification

Slow Infusion of Glucose
Feeding protocols for ICU patients vary by country and region. However, the typical feeding protocol typically consists of a very low number of calories being slowly infused. The infusion is either (nearly) continuous, or given over a 1-3 hour period, 2-4 bmes daily. Figure 1 shows the glucose response for a 400 calorie input infused gradually over 1% minutes for both a normal, non-diabetic response and for the optim~l infusion for a diabetic individual, which is an ideal flat line. Note that the optimal result is not truly flat and G@) varies between G = +/-0.01 mmoVL, as shown in Figure 2 . Figure 3 shows the insulin input profdes for both ass. Note that the optimal insulin infusion orofile is essentiallv an iniection at the fust art of the feeding penod and-khat the a m under the optimal and nurmal cunes, rcprcscntinr! tho tutal insulin infusvd. 1s P , I , I
P = P i r ) + P~o ) r ( n r p , ) ( P ( r ) + P (~) ) + n p ,~( r )
approximately thd same. -
(7)
The optimal solution includes first and second derivatives of the exogenous glucose input PO, as might be expected in solving a series of two first order differentid equations to obtain lhe algebraic solution the third equation in Equation (6). However, it is unrealistic to implement in cases where P@) is not known a priori. Since u(t) can become negative it may be necessary to infuse additional glucose of the first 01 second derivatives of P(f) are significantly negative in value. Equation (7) is also an explicit function of the time constants and other model parameters subjecting it to potential modelling error. This solution does act as a benchmark for the performance of other controllers, as well as being suitahle for cases where the glucose input is weU known and controlled, such as in critical care and other managed care seltings.
Note that the steady-state insulin infusion without exogenous glucose input, u(r)=nVJ8=us wrresponds . . 
42'Multiple Meal Glucose Input
The oral glucose tolerance test (OGlT) is a large step input test of the glucose regulatory system often performed to diagnose diabetes. A fasting subject consumes 400-800 calories of glucose 'and the response is observed. The OGlT input m y be modelled by using the lognormal distribution defined in Equation (8).
p(t) = p e-"llnBl)-r)'
Where P, is the peak value and a, b and c are constants, which determine the slopes and curvature.
A multiple meal glucose input can be constructed from this form of input. The specific input is designed to be extreme and its inputs vary in magnitude fiom 50-400 calories in two g~oups. at f = 0,lOJO minutes and at t = 210 and 300 minutes. At the end of 6 hours, the total intake of glucose into the body is over 1000 calories with 1000 calories input over the first 4 hours.
As seen in Figure 4 , the input profile provides an extreme test with large variations over time that ace
signifi&ntly greater than what is typically encountered man ICU setting to provide a very rigorous test and optimally controlled diabetic individuals. Figure 6 shows the insulin infusion rate for the same cascs. Figure 5 has the same essentially flat glucose response for the optimal case, as it did for the slow infusion. However, the cost of obtaining this response is seen in Figure 6 , where the insulin response for the optimal case consists of steep, sudden infusions that mimic injection profiles as each feeding infusion starts. However, due to the very steep slopes involved in the input there arc times where small infusions of extra glucose would be required given the demand for "negative" insulin in tho figure. This limitation of the optimal result can be quantified by the demand for what arc essentially insulin injections of I -3 U followed in the two largest cases by small glucose infusions to account for the demand for 0.3U withdrawals of insulin from the subcutaneous area. The normal insulin response in Figure 6 is shaped very much like the input itself, as would be expected although it appears flat in the figure.
Summary of Results
The optimal controller is seen to provide, with.no additional feedback an ideal, flat line glucose response for both a normal ICU feeding profile and an extreme case. The extreme case does lead to potential problems with the demand for negative insulin that would require an additional, uncorrected glucose infusion. However.
this case is extremc and not representative of any acccpted glucose feeding protocol for critical care patients in either rapidity of infusion, or total amount of calories given. In each case, the normal response was exceeded and tight, nearly perfect glucose control, which is very important for some classes of critical care patients, was maintained.
. , , , ,
Conclusions
The emergence of glucose sensors capable of providing blood glucose readings at a very high rate is investigated along with the ability to automate insulin infusion for diabetic and hyperglycemic ICU patients. ICU patients present a special case where the feeding protocols tend to consist of infrequent, slow or uniform infusions of smaller amounts of glucose. As a result, the glucose input profile is a h o w n and this data can be used to advantage. Although the optimal controller developed does not require feedback of the glucose value these sensors can be used for other forms of feedback as needed and to monitor patient response for safety.
The optimal infusion control law developed .is an entirely a function of patient paranieters and the glucose input profile. For the slower infusions typically encountered in ICU patients the optimal control law can provide a nearly perfectly flat glucose response with no need for additional glucose infusion for stabilit$ For more extreme tests, such as the multimeal test presented, some glucose infusion is necessary, however the glucose response curve remains flat. In both cases these ideal results outperfom normal response, in addition to which ICU patients can often be hyperglycemic due to physiological stress even with no previous diabetic history. Overall, an optimal control law has been developed and tight, nearly idcal glucose regulation shown for ICW scenarios where the glucose input is a known, slow-moving function. 
